Ionis Pharmaceuticals
Trade Ionis Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
With a market cap of 7.13B, Ionis Pharmaceuticals(IONS) trades at $43.88. The stock has a price-to-earnings ratio of -12.36.
During the trading session on 2026-10-25, Ionis Pharmaceuticals(IONS) shares reached a daily high of $43.93 and a low of $42.62. At a current price of $43.88, the stock is +3.0% higher than the low and still -0.1% under the high.
Trading activity shows a volume of 3.02M, compared to an average daily volume of 2.7M.
Over the past 52 weeks, Ionis Pharmaceuticals(IONS) stock has traded between a high of $86.74 and a low of $42.08.
Over the past 52 weeks, Ionis Pharmaceuticals(IONS) stock has traded between a high of $86.74 and a low of $42.08.
IONS News
The latest update is out from Ionis Pharmaceuticals ( (IONS) ). On October 23, 2026, Ionis’ partner Roche reported late‑breaking Phase 3 data from the ongoing...
Ionis Pharmaceuticals (IONS) partner Roche (RHHBY) announced late-breaking oral presentation data from the ongoing Phase 3 IMAgINATION study in adults with prim...
Ionis Pharmaceuticals (IONS) was granted FDA orphan designation for a treatment of Dravet syndrome, according to a post on the agency’s website. Published firs...
Analyst ratings
86%
of 28 ratingsMore IONS News
Ionis Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Lebowitz from BMO Capital upgraded the rating...
Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced that the FDA has approved Hibsago for the treatment of chronic hepatitis B, or CHB, virus infection in...
Ionis Pharmaceuticals (IONS) just picked up a key regulatory boost in Europe, with the EMA’s CHMP issuing a positive opinion to extend TRYNGOLZA’s indication fo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.